One of the biggest barriers research and academic institutions face is the ability to get discoveries made in the lab into clinical testing. The new Exploratory IND guidance emphasizes the flexibility available to researchers when conducting early clinical testing of these cutting-edge treatments. As we enter the era of personalized medicine, these exploratory approaches enable scientists to take full advantage of new technologies to target the development of more individualized therapies.

One of the biggest barriers research and academic... | Andrew von Eschenbach

One of the biggest barriers research and academic institutions face is the ability to get discoveries made in the lab into clinical testing. The new Exploratory IND guidance emphasizes the flexibility available to researchers when conducting early clinical testing of these cutting-edge treatments. As we enter the era of personalized medicine, these exploratory approaches enable scientists to take full advantage of new technologies to target the development of more individualized therapies. - Andrew von Eschenbach


Style Oval Thought Bubble

One of the biggest barriers research and academic institutions face is the ability to get discoveries made in the lab into clinical testing. The new Exploratory IND guidance emphasizes the flexibility available to researchers when conducting early clinical testing of these cutting-edge treatments. As we enter the era of personalized medicine, these exploratory approaches enable scientists to take full advantage of new technologies to target the development of more individualized therapies. Andrew von Eschenbach

Style Green Rectangle Speech Bubble

One of the biggest barriers research and academic institutions face is the ability to get discoveries made in the lab into clinical testing. The new Exploratory IND guidance emphasizes the flexibility available to researchers when conducting early clinical testing of these cutting-edge treatments. As we enter the era of personalized medicine, these exploratory approaches enable scientists to take full advantage of new technologies to target the development of more individualized therapies. Andrew von Eschenbach

Style Just Basics

One of the biggest barriers research and academic institutions face is the ability to get discoveries made in the lab into clinical testing. The new Exploratory IND guidance emphasizes the flexibility available to researchers when conducting early clinical testing of these cutting-edge treatments. As we enter the era of personalized medicine, these exploratory approaches enable scientists to take full advantage of new technologies to target the development of more individualized therapies. Andrew von Eschenbach

Style PublicSecret

One of the biggest barriers research and academic institutions face is the ability to get discoveries made in the lab into clinical testing. The new Exploratory IND guidance emphasizes the flexibility available to researchers when conducting early clinical testing of these cutting-edge treatments. As we enter the era of personalized medicine, these exploratory approaches enable scientists to take full advantage of new technologies to target the development of more individualized therapies. Andrew von Eschenbach

Style Wild Strawberries

One of the biggest barriers research and academic institutions face is the ability to get discoveries made in the lab into clinical testing. The new Exploratory IND guidance emphasizes the flexibility available to researchers when conducting early clinical testing of these cutting-edge treatments. As we enter the era of personalized medicine, these exploratory approaches enable scientists to take full advantage of new technologies to target the development of more individualized therapies. Andrew von Eschenbach

Style Green Card

One of the biggest barriers research and academic institutions face is the ability to get discoveries made in the lab into clinical testing. The new Exploratory IND guidance emphasizes the flexibility available to researchers when conducting early clinical testing of these cutting-edge treatments. As we enter the era of personalized medicine, these exploratory approaches enable scientists to take full advantage of new technologies to target the development of more individualized therapies. Andrew von Eschenbach

Other embedding Options

If you want to embed quote of the day quotes or want to see other display style options visit our sample page to see all the options.

Learn more about Joomla Quotes Extensions and wordpress extensions.

Cut and paste the following quote id in joomla module / wordpress widget options to display this quote in your webpage. Learn more about Joomla Quotes Extensions and wordpress extensions.

The following will embed an image.You can easily copy and paste it in email or presentations etc. If you want to embed quote of the day quotes or want to see other style options visit our sample page to see all the options.


If you are using this quote in any webpage , printmedia or any other places please use the following methods to cite this quotation.

MLA Style Citation
"A quote by Andrew von Eschenbach" theysaidso.com,2022. May 28, 2022. https://theysaidso.com/quote/andrew-von-eschenbach-one-of-the-biggest-barriers-research-and-academic-institut
APA Style Citation
"A quote by Andrew von Eschenbach" (n.d.). theysaidso.com. Retrieved May 28, 2022, from theysaidso.com web site : https://theysaidso.com/quote/andrew-von-eschenbach-one-of-the-biggest-barriers-research-and-academic-institut
Chicago Style Citation
"A quote by Andrew von Eschenbach". theysaidso.com, 2022. https://theysaidso.com/quote/andrew-von-eschenbach-one-of-the-biggest-barriers-research-and-academic-institut , accessed May 28, 2022.